News from NORD

More Than 100 Patient Organizations Join NORD in Supporting the RARE Act


 

NORD has sent a letter to Congress, signed by more than 100 patient advocacy organizations, in support of the Rare Disease Advancement, Research, and Education Act of 2018 (H.R.5115) or the “RARE Act of 2018.” Read NORD’s letter to see how this proposed legislation would help patients and families affected by rare diseases, medical researchers, and clinicians seeking to provide optimal care for their patients.

Recommended Reading

Osteogenesis Imperfecta Foundation Plans Conference
Clinician Reviews
Progeria Research Foundation Scientific Workshop Planned
Clinician Reviews
Serotonin syndrome risk with triptans and antidepressants ‘very low’
Clinician Reviews
March 2018: Click for Credit
Clinician Reviews
Monitoring for Infection in MS Patients
Clinician Reviews
The ACA and Multiple Sclerosis
Clinician Reviews
Chikungunya infection in children masquerades as SJS-TEN
Clinician Reviews
Register Now for NORD’s Rare Impact Awards Celebration
Clinician Reviews
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
Clinician Reviews
RFPs Available for the Study of Three Rare Diseases
Clinician Reviews